Make HETLIOZ LQ liquid formulation available
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 10 Feb 2021
- Due
- 31 Mar 2021
- Delivered
- March 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“the HETLIOZ LQTM liquid formulation, for children with SMS, is expected to be available in the first quarter of 2021.”
What we found
Evidence strength A What the grades mean
Vanda Pharmaceuticals confirmed that the HETLIOZ LQ liquid formulation became available in the first quarter of 2021, specifically noting a March 2021 launch date.
-
A Vanda Pharmaceuticals Inc. 10-K filed 2022-02-24
“HETLIOZ® capsules, for adults with SMS, were immediately available after approval and the HETLIOZ LQTM liquid formulation, for children with SMS, became available in March 2021.” ✓ confirmed on the page
-
A Vanda Pharmaceuticals Inc. 10-K filed 2022-02-24
“We commercially launched HETLIOZ® capsules in the U.S. in April 2014 and the oral suspension in March 2021.” ✓ confirmed on the page
Checked 25 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Product other
- Indicative materiality
- Low rules
- Action
- Make
- Deliverable
- HETLIOZ LQ liquid formulation
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- Medium
- Specificity
- High
- Depends on
- Supplier
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Vanda Pharmaceuticals Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-VNDA-023460 · Corrections policy